<p><h1>Core Biopsy Needles Market Size, Share & Trends Analysis Report By Material, By Type, By End-user, By Region, And Segment Forecasts, 2024 - 2031</h1></p><p><strong>Core Biopsy Needles Market Analysis and Latest Trends</strong></p>
<p><p>Core biopsy needles are medical devices used for the extraction of tissue samples from any part of the body. They are mainly utilized in diagnostic procedures to determine the presence of cancer or other abnormal tissues. Core biopsy needles consist of a hollow tube with a sharp cutting edge that captures a cylindrical core sample of tissue during the procedure.</p><p>The global core biopsy needles market is witnessing significant growth due to several factors. Firstly, the rising prevalence of cancer worldwide is a major driving force, as core biopsy needles are crucial for early and accurate diagnosis of various types of cancers. Additionally, the increasing awareness about the importance of regular screening for the early detection of cancer is fueling the demand for core biopsy needles.</p><p>Moreover, advancements in imaging technologies and minimally invasive surgical procedures have also contributed to market growth. These advancements have improved the accuracy and safety of core biopsies, thereby increasing their adoption. Furthermore, the growing geriatric population, who are more susceptible to cancer and other diseases, is likely to boost the usage of core biopsy needles in the coming years.</p><p>The market is also witnessing various trends that are shaping its growth trajectory. For instance, there is a rising preference for vacuum-assisted biopsy needles, which provide greater control, increased sample sizes, and higher accuracy. Another trend is the integration of core biopsy needles with imaging technologies such as ultrasound or MRI, enabling real-time guidance during the procedure.</p><p>In conclusion, the global core biopsy needles market is expected to grow at a CAGR of 9.70% during the forecast period. Factors such as the increasing prevalence of cancer, advancements in medical technologies, and the growing elderly population are driving this growth. Additionally, the market is witnessing trends such as the preference for vacuum-assisted biopsy needles and the integration of imaging technologies with core biopsy devices.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reportprime.com/enquiry/request-sample/8315">https://www.reportprime.com/enquiry/request-sample/8315</a></p>
<p>&nbsp;</p>
<p><strong>Core Biopsy Needles Major Market Players</strong></p>
<p><p>The core biopsy needles market is highly competitive, with several key players dominating the industry. Some of the major players in the market include BD (Bard), Hologic, Mammotome, Argon Medical Devices, SOMATEX Medical Technologies, Invivo, M.D.L., Sterylab, UROMED, and Biopsybell.</p><p>BD (Bard) is a leading player in the core biopsy needles market, offering a wide range of products for both diagnostic and therapeutic purposes. The company has a strong market presence and is known for its high-quality products. BD (Bard) has experienced steady market growth over the years, driven by increasing demand for minimally invasive and accurate biopsy procedures. The company's future growth prospects are promising, as it continues to invest in research and development to develop innovative products.</p><p>Hologic is another key player in the core biopsy needles market. The company offers a comprehensive portfolio of biopsy products, including advanced imaging and tissue acquisition systems. Hologic has a strong market position and is known for its state-of-the-art technology and superior customer service. The company has witnessed significant market growth, particularly driven by the rising prevalence of breast cancer and increasing adoption of minimally invasive biopsy procedures. Hologic's future growth is expected to remain robust, fueled by new product launches and expanding market presence.</p><p>Mammotome, a subsidiary of Leica Biosystems, specializes in breast biopsy devices and is a significant player in the core biopsy needles market. The company's products are designed to provide accurate and efficient tissue sampling. Mammotome has witnessed substantial market growth, owing to its focus on technological advancements and strong customer relationships. The company's future growth is expected to be driven by the increasing demand for minimally invasive breast biopsy procedures and the introduction of advanced biopsy systems.</p><p>While the specific sales revenue figures for the mentioned companies are not available, the core biopsy needles market is estimated to be valued at around $692 million in 2020 and is expected to grow at a CAGR of approximately 5.6% from 2021 to 2028. The market growth is primarily driven by factors such as the increasing incidence of cancer, advancements in biopsy techniques, and the rising awareness about early disease detection and diagnosis.</p><p>In conclusion, the core biopsy needles market is highly competitive, with players like BD (Bard), Hologic, and Mammotome dominating the industry. These companies have experienced significant market growth and are expected to witness strong future growth, driven by technological advancements, increasing demand for minimally invasive procedures, and growing awareness about early disease detection. The market size of the core biopsy needles market is estimated to be around $692 million and is projected to grow at a CAGR of approximately 5.6% from 2021 to 2028.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Core Biopsy Needles Manufacturers?</strong></p>
<p><p>The Core Biopsy Needles market is experiencing significant growth due to the increasing prevalence of cancer and the rising demand for minimally invasive procedures. The market is expected to witness a CAGR of X% during the forecast period. Technological advancements, such as the development of vacuum-assisted biopsy systems, are further driving market growth. Additionally, the increasing adoption of biopsy procedures in emerging economies and advancements in precision medicine are likely to create lucrative opportunities in the market. However, limited reimbursement policies and strict regulatory requirements may hinder market growth. Overall, the Core Biopsy Needles market is expected to expand with favorable growth trends and a positive future outlook.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reportprime.com/enquiry/pre-order/8315">https://www.reportprime.com/enquiry/pre-order/8315</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Core Biopsy Needles Market Analysis by types is segmented into:</strong></p>
<p><ul><li>14G-18G</li><li><14G</li><li>>18G</li></ul></p>
<p><p>The core biopsy needles market is categorized into three types based on gauge size: 14G-18G, <14G, and >18G. The 14G-18G needles have a gauge size ranging between 14 and 18, providing a balance between tissue yield and patient comfort. The needles with a gauge size of less than 14G offer higher tissue yield but may cause more discomfort during procedures. Conversely, the needles with a gauge size greater than 18G offer greater patient comfort but may provide lower tissue yield during biopsies.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reportprime.com/checkout?id=8315&price=3590">https://www.reportprime.com/checkout?id=8315&price=3590</a></p>
<p>&nbsp;</p>
<p><strong>The Core Biopsy Needles Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Lung Cancer</li><li>Liver Cancer</li><li>Breast Cancer</li><li>Prostate Cancer</li><li>Other</li></ul></p>
<p><p>Core biopsy needles are medical devices used for obtaining tissue samples from various organs in the body. In the context of lung cancer, these needles are utilized to extract tissue samples from suspicious nodules or masses in the lungs for diagnostic purposes. Similarly, in liver cancer, core biopsy needles aid in obtaining liver tissue samples to confirm the presence of malignancy. For breast cancer, these needles are employed to retrieve tissue samples from breast lumps or abnormalities. In prostate cancer, core biopsy needles assist in collecting prostate gland samples to assess tumor presence. These needles also find applications in other cancer types where tissue sampling is required for accurate diagnosis and treatment planning.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Core Biopsy Needles Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The global core biopsy needles market is anticipated to witness substantial growth across various regions, including North America (NA), Asia-Pacific (APAC), Europe, the United States of America (USA), and China. Among these regions, North America is expected to dominate the market with the largest market share percentage valuation. The robust growth in North America can be attributed to the rising prevalence of cancer, increasing healthcare infrastructure, and favorable reimbursement policies. Similarly, Europe is projected to hold a significant share in the market due to the increasing adoption of minimally invasive procedures and advancements in healthcare technology. Meanwhile, Asia-Pacific, including China, is anticipated to experience remarkable growth owing to the expanding geriatric population and improving healthcare facilities in emerging economies.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reportprime.com/checkout?id=8315&price=3590">https://www.reportprime.com/checkout?id=8315&price=3590</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reportprime.com/enquiry/request-sample/8315">https://www.reportprime.com/enquiry/request-sample/8315</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reportprime.com/</p>